Versigent (NYSE:VGNT) Trading Down 4.9% – Here’s What Happened

Versigent (NYSE:VGNTGet Free Report) traded down 4.9% during mid-day trading on Friday . The stock traded as low as $45.17 and last traded at $45.2150. Approximately 270,343 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 1,719,434 shares. The stock had previously closed at $47.52.

Analyst Ratings Changes

Several research analysts recently weighed in on VGNT shares. TD Cowen boosted their price target on shares of Versigent from $49.00 to $58.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Oppenheimer set a $50.00 target price on Versigent in a research note on Tuesday, July 21st. UBS Group reduced their target price on Versigent from $58.00 to $55.00 and set a “buy” rating for the company in a report on Thursday, July 9th. The Goldman Sachs Group reiterated a “buy” rating and set a $59.00 price target on shares of Versigent in a report on Wednesday, August 5th. Finally, Argus boosted their price objective on Versigent from $50.00 to $54.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Eleven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $54.00.

Check Out Our Latest Stock Analysis on VGNT

Versigent Stock Down 3.9%

The company has a debt-to-equity ratio of 7.29, a current ratio of 1.40 and a quick ratio of 1.09. The company has a market cap of $3.23 billion and a P/E ratio of 23.77. The company’s 50-day simple moving average is $44.84.

Versigent (NYSE:VGNTGet Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.29 billion. As a group, equities analysts anticipate that Versigent will post 7.23 EPS for the current fiscal year.

Versigent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 18th. Stockholders of record on Friday, September 4th will be given a $0.13 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, September 4th.

Insider Buying and Selling

In related news, Director Kevin Clark sold 74,130 shares of the company’s stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $45.67, for a total transaction of $3,385,517.10. Following the sale, the director owned 124,849 shares of the company’s stock, valued at approximately $5,701,853.83. This represents a 37.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Institutional Investors Weigh In On Versigent

Institutional investors and hedge funds have recently made changes to their positions in the business. Allianz Asset Management GmbH purchased a new position in shares of Versigent during the second quarter worth about $20,602,000. HBK Investments L P purchased a new stake in shares of Versigent in the 2nd quarter valued at $14,439,000. Steamboat Capital Partners LLC bought a new position in shares of Versigent during the second quarter valued at about $10,385,000. WINTON GROUP Ltd bought a new position in Versigent during the 2nd quarter worth approximately $8,397,000. Finally, Nan Shan Life Insurance Co. Ltd. bought a new stake in Versigent in the second quarter valued at approximately $5,400,000.

Versigent Company Profile

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

See Also

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.